Detillio Joshua Insider Trades

Insider Trading History

Track insider trading activity for Detillio Joshua. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nutex Health
Nutex Health NUTX
Chief Operating Officer
Holding Value $876k 6,481 shares
Last Trade
Apr 04, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$32.6k 452 shares
$72.10
$135.10
Nutex Health
Nutex Health NUTX
Chief Operating Officer
Holding Value $650k 4,808 shares
Last Trade
Aug 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.9k 575 shares
$20.63
$135.10
Nutex Health
Nutex Health NUTX
Chief Operating Officer
Holding Value $572k 4,233 shares
Last Trade
Aug 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.2k 1,300 shares
$17.85
$135.10
Nutex Health
Nutex Health NUTX
Chief Operating Officer
Holding Value $8.61M 63,750 shares
Last Trade
Jun 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$379k 63,750 shares
$5.95
$135.10
Nutex Health
Nutex Health NUTX
Chief Operating Officer
Holding Value $3.96M 29,333 shares
Last Trade
Jun 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$108k 20,000 shares
$5.40
$135.10
Nutex Health
Nutex Health NUTX
Chief Operating Officer
Holding Value $18.9M 140,000 shares
Last Trade
Nov 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.15M 140,000 shares
$36.80
$135.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up